Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology

Study of the Therapeutic Response and Survival of Patients with Metastatic Colorectal Cancer (stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme® (ONCOGRAM)

NCT03133273 ·Status: COMPLETED ·Phase: NA

Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer

NCT02774512 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer

NCT02090101 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer

NCT01486251 ·Status: COMPLETED ·Phase: NA

Analysis of Circulating Tumor DNA to Monitor Metastatic Colorectal Cancer Treatment

NCT01983098 ·Status: UNKNOWN

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

NCT00975897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab

NCT01436617 ·Status: COMPLETED

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

NCT00003186 ·Status: COMPLETED ·Phase: NA

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

NCT00835679 ·Status: TERMINATED ·Phase: EARLY_PHASE1

A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer

NCT00801294 ·Status: COMPLETED ·Phase: PHASE2

Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

NCT01409005 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.

NCT04660812 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer

NCT00023933 ·Status: COMPLETED ·Phase: PHASE1

CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

NCT04120701 ·Status: RECRUITING ·Phase: PHASE3

Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer

NCT00039273 ·Status: COMPLETED ·Phase: PHASE2

Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer

NCT05299840 ·Status: RECRUITING ·Phase: NA

The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients

NCT04397575 ·Status: COMPLETED

Edrecolomab in Treating Patients With Stage II Colon Cancer

NCT00002968 ·Status: COMPLETED ·Phase: PHASE3

Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer

NCT04612309 ·Status: ACTIVE_NOT_RECRUITING

Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer

NCT03785873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .

NCT02788006 ·Status: COMPLETED ·Phase: PHASE2

Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers

NCT06425133 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib

NCT04874207 ·Status: COMPLETED ·Phase: PHASE4

Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer

NCT02751177 ·Status: COMPLETED ·Phase: NA

Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.

NCT05498051 ·Status: COMPLETED ·Phase: NA